| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |